TLX•benzinga•
UBS Initiates Coverage On Telix Pharmaceuticals with Buy Rating, Announces Price Target of $21
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 15, 2024 by benzinga